Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure: AQUAMARINE Study

Trial Profile

Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure: AQUAMARINE Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Furosemide
  • Indications Decompensated heart failure; Heart failure; Renal failure
  • Focus Therapeutic Use
  • Acronyms AQUAMARINE
  • Most Recent Events

    • 16 Nov 2016 Results of secondary analysis (n=184) assessing the prognostic influence of the sodium level trajectory (sodium dipping vs. nonsodium-dipping group) in acute heart failure patients, presented at the 89th Annual Scientific Sessions of the American Heart Association.
    • 01 Feb 2014 Trial design presented at Cardiovascular Drugs & Therapy.
    • 26 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top